Product Profile: Methyl-Tren 4 by Unique Pharma
Methyl-Tren 4 by Unique Pharma features Metribolone (Methyltrienolone) at an ultra-potent concentration of 4 mg/ml in a sterile injectable oil vehicle. Structurally modified with a $17\alpha$-methyl group attached to a 19-nor core, Metribolone stands as one of the most powerful synthetic anabolic-androgenic compounds ever synthesized.
Key Technical Specifications
- Brand / Lab: Unique Pharma
- Product Name: Methyl-Tren 4
- Active Compound: Metribolone (Methyltrienolone)
- Strength / Volume: 4 mg/ml in a 10 ml multi-dose vial
- Anabolic / Androgenic Score: $12,000 / 6,000$ (Testosterone reference = $100 / 100$)
Core Performance Drivers & Physical Impact
- Non-Aromatizing Properties: Complete structural resistance to the aromatase enzyme ensures zero estrogenic conversion, eliminating subcutaneous water retention and bloat.
- Instant Neural & Strength Expansion: Significantly amplifies central nervous system drive, producing immediate strength surges during intense training phases.
- Cortisol Suppression: Binds strongly to glucocorticoid receptors, blunting catabolic signals and protecting lean tissue during aggressive caloric restriction.
- Direct Injectable Delivery: Formulated in a stabilized oil vehicle to ensure direct absorption and consistent systemic delivery compared to oral forms.
Known Limitations & Risk Factors
- Severe Hepatic Burden: The presence of $17\alpha$-alkylation creates intense strain on liver tissues, causing rapid elevation of AST/ALT liver enzymes and potential cholestatic stress.
- Lipid & Vascular Stress: Profoundly disrupts cholesterol balance by severely depressing HDL levels while driving up LDL, resulting in elevated blood pressure and arterial strain.
- Rapid HPG Axis Shutdown: Suppresses endogenous testosterone production almost instantly upon administration.
- Progestogenic Binding: Interacts directly with progesterone receptors, which can trigger progestogenic complications despite the complete absence of estrogen conversion.
- Lack of Medical Approval: Due to its extremely narrow therapeutic window and pronounced toxicity, Metribolone was abandoned during early clinical trials and is not approved for human therapeutic use.
Physiological Stress Points & Manifestations
- Organ Systems: Marked liver enzyme elevation, risk of jaundice, and hepatic stress.
- Cardiovascular Profile: Severe cholesterol skewing (drastic HDL drop), hypertension, and systemic vascular stress.
- Endocrine Health: Complete shutdown of natural hormone synthesis, testicular atrophy, and severe post-exposure hormonal crash.
- Central Nervous System & Mood: Heightened irritability, aggression, insomnia, restless sleep cycles, and anxiety.
- Androgenic Expression: Rapid onset of severe acne, accelerated androgenic alopecia in predisposed individuals, and increased body hair growth.
Eligibility Criteria, Age Limits & Regulatory Status
- Under 21 Years of Age: Strictly Prohibited. Anabolic androgenic exposure during adolescent or early adult development alters endocrine pathways, permanently disrupts natural hormone regulation, and risks premature epiphyseal plate closure in growing bones.
- Adult Threshold: Any handling or research application is strictly limited to fully developed adults (21+ or 25+).
- Sports & Governing Status: Metribolone is classified as a Schedule III controlled substance and is strictly banned by WADA (World Anti-Doping Agency), USADA, and all global athletic federations under prohibited anabolic agents.
- Handling Protocol: Because of its high toxicity profile and sub-milligram potency, exposure should strictly adhere to qualified laboratory standards under professional medical supervision.
Methyl-Tren 4 Injectable Unique Pharma
- Brand: Unique Pharma
- Product Code: Unique Pharma
- Availability: In Stock
-
$100.80

-228x228.jpg)